Financhill
Back

Health Catalyst Quote, Financials, Valuation and Earnings

Health Catalyst Price Quote

$7.66
+0.30 (+4.08%)
(Updated: November 21, 2024 at 5:55 PM ET)

Health Catalyst Key Stats

Sell
38
Health Catalyst (HCAT) is a Sell

Day range:
$7.20 - $7.50
52-week range:
$5.42 - $11.41
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
1.47
P/B ratio:
1.29%

Volume:
472.4K
Avg. volume:
508.9K
1-year change:
-5.03%
Market cap:
$458.2M
Revenue:
$295.9M
EPS:
$-1.35

How Much Does Health Catalyst Make?

Is Health Catalyst Growing As A Company?

  • What Is Health Catalyst's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.03%
  • What Is Health Catalyst's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Health Catalyst Stock Price Performance

  • Did Health Catalyst Stock Go Up Last Month?
    Health Catalyst share price went down by -15.01% last month
  • Did HCAT's Share Price Rise Over The Last Year?
    HCAT share price fell by -5.03% over the past 1 year

What Is Health Catalyst 52-Week High & Low?

Health Catalyst Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Health Catalyst?

  • How Much Debt Does Health Catalyst Have?
    Total long term debt quarterly is $345M
  • How Much Cash Does Health Catalyst Have?
    Cash and short term investments quarterly total is $387.3M
  • What Is Health Catalyst’s Book Value Per Share?
    Book value per share is 5.83

Is Health Catalyst Cash Flow Positive?

  • What Is HCAT Cash Flow From Operations?
    Cash flow from operations (TTM) is -$955K
  • What Is Health Catalyst’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $114.5M
  • What Is Health Catalyst’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $119.8M

Health Catalyst Return On Invested Capital

  • Is Management Doing A Good Job?
    HCAT return on invested capital is -12.86%
  • What Is Health Catalyst Return On Assets?
    ROA measures how assets are converting to revenues and is -10.95%
  • What Is HCAT Return On Equity?
    ROE is a measure of profitability and is -21.76%

Health Catalyst Earnings Date & Stock Price

Health Catalyst Competitors

  • Who Are Health Catalyst's Competitors?
    Below is a list of companies who compete with Health Catalyst or are related in some way:
    • Addus HomeCare Corp (ADUS)
    • Amedisys Inc (AMED)
    • Option Care Health Inc (OPCH)
    • OptimizeRx Corp (OPRX)
    • Regional Health Properties Inc (RHE)

Health Catalyst Dividend Yield

Health Catalyst Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -25.42%
Revenue: 3.5% -0.13%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 0
Price Target: 11.63
Upside from Last Price: 57.95%

Major Shareholders

  • How many HCAT shares are owned by institutional investors?
    83.2M HCAT shares are owned by institutional investors
  • How many HCAT shares are owned by insiders?
    3.6M HCAT shares are owned by insiders